magicinepharma01

PERJETA® (Pertuzumab) has been authorized for use in combination with chemotherapy along with Herceptin® (trastuzumab) for the treatment of HER2-positive breast cancer. Pertuzumab 450 mg Injection Price should be implemented as a characteristic of all therapeutic processes for patients with early-stage breast cancer regimen